newsfilter
← Latest News
GlobeNewswire·

Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

- Company remains on track to report pivotal data from lead program, ADAIR, in second half 2021 - Novel abuse-deterrent platform technology enables pipeline expansion opportunities across multiple drugs and indications PHILADELPHIA, PA, May 13